[1] The prolonged half-life also has implications for drug washout following discontinuation
However, theres a newer medication called Mounjaro (tirzepatide), which acts on both GLP-1 and GIP receptors, offering even more powerful results for managing blood sugar and promoting weight loss
The final determination will depend on the overall risk-benefit profile established in large-scale, long-term cardiovascular outcome trials
Research Disclaimer All Nexyra Lab products are for in vitro research and laboratory use by qualified researchers only
Stphanie Cozzolino Endocrinologista e Clnica Mdica.
Recent FDA rulings, however, have forced Fella Health to prescribe only name-brand medications, like Wegovy and Zepbound, which are more expensive, but generally safer GLP-1 options